换话题 发表于 2025-3-26 21:05:48
Data Visualization Strategies to Communicate PRO Data to Patients and Clinicianshealth condition and/or related treatment. Whether PROs are assessed as part of an individual’s care (e.g., for symptom assessment or monitoring) or as part of research (e.g., observational studies or evaluating intervention impacts), their value depends on patients and clinicians accurately interpr灾祸 发表于 2025-3-27 04:43:48
Cross-Cultural Considerations in Health-Related Quality of Life in Cancerway to improve patient’s health-related quality of life (HRQOL). Cancer care is no exception, with HCPs having to navigate through difficult topics of breaking the diagnosis, treatment options, pain management, and at times end-of-life care, not just with the patient but with their family as well..Tnonplus 发表于 2025-3-27 06:38:13
http://reply.papertrans.cn/43/4221/422039/422039_33.png画布 发表于 2025-3-27 13:11:58
Decision-Making in the Context of Funding Cancer Therapyr at a fraction of the market price. Whilst this is an excellent outcome for patients, this chapter considers the health economic aspects of decisions to fund such treatments. Governments, like us, do not have bottomless buckets of money. Therefore, decisions must be made that aim to provide the bes空中 发表于 2025-3-27 14:58:39
Satisfaction with Cancer Carewestern countries, although several studies on patient satisfaction have also been conducted in other regions. Patient satisfaction assessment instruments have been developed and are now routinely utilized in many countries; however, initiatives to elaborate and validate such questionnaires across cIngenuity 发表于 2025-3-27 21:11:07
Quality of Life and Cancer-Related Fatigue: Prevalence, Assessment and Interventionsaustion, weakness or a loss of activity due to cancer diagnosis or treatment and is described as a multidimensional construct including physical, cognitive and emotional dimensions. Although there have been a lot of research activities, there is no clear pathogenetic model to explain how the multica兵团 发表于 2025-3-27 23:57:17
http://reply.papertrans.cn/43/4221/422039/422039_37.pngBRIBE 发表于 2025-3-28 03:32:48
http://reply.papertrans.cn/43/4221/422039/422039_38.png场所 发表于 2025-3-28 07:03:18
http://reply.papertrans.cn/43/4221/422039/422039_39.pngEvocative 发表于 2025-3-28 13:56:24
http://reply.papertrans.cn/43/4221/422039/422039_40.png